Ontwikkeling en validatie van een screeningsinstrument voor Obstructief Slaap Apneu Syndroom.

Development and validation of a screening instrument for Obstructive Sleep Apnea Syndrome in healthy workers.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON25523

Enrollment

300

Registered

2011-01-03

Start date

2011-02-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep Apnea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects have to have a fixed employment contract with Philips Nederland; 2. Subjects have to work at either Philips Nederland gebouw VB, Eindhoven or Philips Healthcare, Best.

Exclusion criteria

Exclusion criteria: Temporary workers.

Design outcomes

Primary

Measure	Time frame
Find the best 2 or 3 step strategy for screening of OSAS in a Dutch employee population to optimize a large scale screening program. Home PSG with the ALICE PDX, combined with answers on sleepiness will be used for confirmation. This includes the following: 1. Which questionnaire, or set of questions has the highest accuracy in terms of sensitivity, specificity and positive and negative predictive value; 2. Define the low and high cut-off values of the used questionnaires for negative and positive test results; 3. Are limited IV home sleep studies in this population feasible; 4. What is the accuracy of the complete strategy.	—

Measure

Time frame

Find the best 2 or 3 step strategy for screening of OSAS in a Dutch employee population to optimize a large scale screening program. Home PSG with the ALICE PDX, combined with answers on sleepiness will be used for confirmation. This includes the following: 1. Which questionnaire, or set of questions has the highest accuracy in terms of sensitivity, specificity and positive and negative predictive value; 2. Define the low and high cut-off values of the used questionnaires for negative and positive test results; 3. Are limited IV home sleep studies in this population feasible; 4. What is the accuracy of the complete strategy.

—

Secondary

Measure	Time frame
1. Calculate the costs of the strategy; 2. Estimate the prevalence of OSAS in this population; 3. Estimate the prevalence of Excessive Daytime Sleepiness in this population.	—

Contacts

Public ContactM.M. Eijsvogel

Medisch Spectrum Twente Department of Pulmonary Medicine

m.eijsvogel@mst.nl+31 (0)53 4872610

Outcome results